Irisoquin C



Compound IDCDAMM01055
Common nameIrisoquin C
IUPAC name2-hydroxy-5-methoxy-3-nonadecylcyclohexa-2,5-diene-1,4-dione
Molecular formulaC26H44O4

Experimental data

Retention time17.92
Adduct[M+Na]+
Actual mz443.318
Theoretical mz443.313
Error11.24
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.5289

Identifiers and class information

Inchi keySUAQMIMGKZVLBE-UHFFFAOYSA-N
SmilesO=C1C=C(OC)C(=O)C(=C1O)CCCCCCCCCCCCCCCCCCC
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)5
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)20
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)420.631
Computed dipole moment(dipole)2.171
Total solvent accessible surface area (SASA)938.222
Hydrophobic component of SASA (FOSA)764.224
Hydrophilic component of SASA (FISA)139.765
Pie component of the SASA (PISA)34.233
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1644.19
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)5.5
Free energy of solvation of dipole (dip^2/V)0.0028676
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0058622
Globularity descriptor (glob)0.718061
Predicted polarizability in cubic angstroms (QPpolrz)47.132
Predicted hexadecane/gas partition coefficient (QPlogPC16)15.69
Predicted octanol/gas partition coefficient (QPlogPoct)18.921
Predicted water/gas partition coefficient (QPlogPw)5.631
Predicted octanol/water partition coefficient (QPlogPo/w)6.376
Predicted aqueous solubility (QPlogS)-8.045
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.929
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.257
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)468.279
Predicted brain/blood partition coefficient (QPlogBB)-2.449
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)217.874
Predicted skin permeability, log Kp (QPlogKp)-2.055
PM3 calculated ionization potential (IP(ev))9.749
PM3 calculated electron affinity (EA(eV))1.77
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)1.14
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)84.309
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P10635CYP2D6Cytochrome P450 2D6T57392SwissTargetPrediction
P11712CYP2C9Cytochrome P450 2C9T19244SwissTargetPrediction
P08684CYP3A4Cytochrome P450 3A4T37848SwissTargetPrediction
P14555PLA2G2APhospholipase A2 group IIAT19160SwissTargetPrediction
P98170XIAPInhibitor of apoptosis protein 3T16769SwissTargetPrediction
P11511CYP19A1Cytochrome P450 19A1T13260SwissTargetPrediction
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
P09917ALOX5Arachidonate 5-lipoxygenaseT00140SwissTargetPrediction and SEA
P08183ABCB1P-glycoprotein 1T25258SwissTargetPrediction
P10827THRAThyroid hormone receptor alphaT79591SEA
P10828THRBThyroid hormone receptor beta-1T98933SEA
P27695APEX1DNA-(apurinic or apyrimidinic site) lyaseT13348SEA
Q92831KAT2BHistone acetyltransferase PCAFT16902SwissTargetPrediction
P08842STSSteryl-sulfataseT33489SEA
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
P10826RARBRetinoic acid receptor betaT61657SEA
O95136S1PR2Sphingosine 1-phosphate receptor Edg-5T47888SEA
Q9NQS5GPR84G-protein coupled receptor 84T98091SEA
Q9UJM8HAO1Hydroxyacid oxidase 1T63170SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T57392DI0214Insomnia[ICD-11: 7A00-7A0Z]P10635CYP2D6
T19244DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P11712CYP2C9
T37848DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P08684CYP3A4
T19160DI0062Breast cancer[ICD-11: 2C60-2C6Y]P14555PLA2G2A
T16769DI0259Metastatic lymph node neoplasm[ICD-11: 2D60]P98170XIAP
T13260DI0062Breast cancer[ICD-11: 2C60-2C6Y]P11511CYP19A1
T13260DI0108Cushing syndrome[ICD-11: 5A70]P11511CYP19A1
T00140DI0037Asthma[ICD-11: CA23]P09917ALOX5
T00140DI0147Filariasis[ICD-11: 1F66]P09917ALOX5
T00140DI0403Thrombocytopenia[ICD-11: 3B64]P09917ALOX5
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1
T79591DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P10827THRA
T79591DI0197Hypo-thyroidism[ICD-11: 5A00]P10827THRA
T98933DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P10828THRB
T13348DI0365Retinopathy[ICD-11: 9B71]P27695APEX1
T13348DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P27695APEX1
T33489DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]P08842STS
T61657DI0225Kaposi sarcoma[ICD-11: 2B57]P10826RARB
T47888DI0419Ulcerative colitis[ICD-11: DD71]O95136S1PR2
T98091DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q9NQS5GPR84
T98091DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q9NQS5GPR84
T63170DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]Q9UJM8HAO1

Copyright © 2025